Emerald Acquisition’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
BFA
CWAM
BIT
Emerald Acquisition's RARE Position: Q3 2016 in Review
Emerald Acquisition reduced its Ultragenyx Pharmaceutical (RARE) stake by 59% in Q3 2016, selling an estimated $465K and leaving 5,100 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #2552.
Emerald Acquisition first reported a position in RARE in Q2 2016 and has held it in 2 quarters since. The position peaked at $606K in Q2 2016. 172 funds tracked by Wall St. Rank hold RARE as of Q3 2016.
- Emerald Acquisition held 5,100 shares of Ultragenyx Pharmaceutical worth $362K as of Q3 2016.
- Emerald Acquisition sold 7,287 Ultragenyx Pharmaceutical shares in Q3 2016, an estimated $465K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2552 holding.
- Emerald Acquisition first reported a position in Ultragenyx Pharmaceutical in Q2 2016 and has held it in 2 quarters since.
- Emerald Acquisition's Ultragenyx Pharmaceutical position peaked at $606K in Q2 2016.
- 172 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2016.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.